NCT04880980View on ClinicalTrials.gov

Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

March 15, 2022

Study Completion Date

March 15, 2022

Conditions
Dermatophyte InfectionTerbinafine Adverse ReactionItraconazole Adverse Reaction
Interventions
DRUG

Terbinafine Pill

Double than usual dose of oral terbinafine pills will be used for treatment purpose in one group.

DRUG

Itraconazole capsule

Double than usual dose of oral itraconazole capsules will be used for treatment purpose in second group.

Trial Locations (1)

46000

Pak Emirates Military Hospital, Rawalpindi

All Listed Sponsors
lead

Pak Emirates Military Hospital

OTHER

NCT04880980 - Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin. | Biotech Hunter | Biotech Hunter